Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

NCT05881135 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT05881135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05881135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
Lead sponsor
Ohio State University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
June 6, 2023
Completion date
April 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19